Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings
About Jinyu Bio-Technology Co.,Ltd.
Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 金宇生物技术股份有限公司2023年度审计报告 | 2024-04-25 | Chinese | |
| 金宇生物技术股份有限公司2023年度独立董事述职报告-张桂红 | 2024-04-25 | Chinese | |
| 金宇生物技术股份有限公司2023年度独立董事述职报告-申嫦娥 | 2024-04-25 | Chinese | |
| 金宇生物技术股份有限公司2023年年度利润分配方案公告 | 2024-04-25 | Chinese | |
| 金宇生物技术股份有限公司对会计师事务所2023年度履职情况评估报告 | 2024-04-25 | Chinese | |
| 金宇生物技术股份有限公司2024年第一季度报告 | 2024-04-25 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 40523382 | 金宇生物技术股份有限公司2023年度审计报告 | 2024-04-25 | Chinese | ||
| 40523260 | 金宇生物技术股份有限公司2023年度独立董事述职报告-张桂红 | 2024-04-25 | Chinese | ||
| 40523251 | 金宇生物技术股份有限公司2023年度独立董事述职报告-申嫦娥 | 2024-04-25 | Chinese | ||
| 40523244 | 金宇生物技术股份有限公司2023年年度利润分配方案公告 | 2024-04-25 | Chinese | ||
| 40523236 | 金宇生物技术股份有限公司对会计师事务所2023年度履职情况评估报告 | 2024-04-25 | Chinese | ||
| 40523233 | 金宇生物技术股份有限公司2024年第一季度报告 | 2024-04-25 | Chinese | ||
| 40523226 | 金宇生物技术股份有限公司关于2023年度计提资产减值准备及坏账核销的公告.docx | 2024-04-25 | Chinese | ||
| 40523219 | 金宇生物技术股份有限公司2023年度审计委员会履职情况报告 | 2024-04-25 | Chinese | ||
| 40523212 | 金宇生物技术股份有限公司第十一届监事会第十三次会议决议公告 | 2024-04-25 | Chinese | ||
| 40523203 | 金宇生物技术股份有限公司2023年度内部控制评价报告 | 2024-04-25 | Chinese | ||
| 40523190 | 内蒙古建中律师事务所关于金宇生物技术股份有限公司2024年第一次临时股东大会的法律意见书 | 2024-03-15 | Chinese | ||
| 40523184 | 金宇生物技术股份有限公司2024年第一次临时股东大会会议决议公告 | 2024-03-15 | Chinese | ||
| 40523165 | 金宇生物技术股份有限公司2024年第一次临时股东大会会议资料 | 2024-03-06 | Chinese | ||
| 40523155 | 金宇生物技术股份有限公司第十一届监事会第十二次会议决议公告 | 2024-02-28 | Chinese | ||
| 40523146 | 金宇生物技术股份有限公司第十一届董事会第十三次会议决议公告 | 2024-02-28 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Jinyu Bio-Technology Co.,Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/56561/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=56561 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=56561 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=56561 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 56561}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Jinyu Bio-Technology Co.,Ltd. (id: 56561)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.